Drugs / JDB153
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07175389 | Oct 2025 → Sep 2027 expected | pancreatic ductal adenocarcinoma | West China Hospital | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT07075419 | Aug 2025 → Jul 2027 expected | hepatocellular carcinoma | West China Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JDB153 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07175389 ↗ |
| Route | Oral | “administered orally” NCT07075419 ↗ |